目的：分析评价视网膜大动脉瘤合并玻璃体积血行玻璃体切割术联合眼内视网膜光凝治疗的临床疗效。 方法：回顾分析2009-01/2011-02在我院住院治疗的11例11眼视网膜大动脉瘤合并玻璃体积血的患者，给予玻璃体切割术联合眼内激光治疗；并对其手术疗效、视力和并发症进行观察分析。 结果：术后随访6～24mo，11例患者玻璃体腔均无再次出血，视网膜大动脉瘤周边血管闭塞，瘤体萎缩、瘢痕化；术后视力0.05～0.4，均有不同程度提高；其中2例2眼术后眼压一过性升高，局部给予降眼压药物治疗后恢复正常。 结论：玻璃体切割术联合眼内视网膜光凝治疗，对视网膜大动脉瘤合并玻璃体积血患者是一种疗效确切的治疗方法。

AIM:To evaluate the surgery treatment efficacy of vitrectomy combined retinal photocoagulation on vitreous hemorrhage associated with retinal arterial aneurysm. METHODS: Retrospective analysis of vitrectomy combined retinal photocoagulation for patients with vitreous hemorrhage associated with retinal arterial aneurysms,11 cases (11 eyes, 4 males, 7 females), from January 2009 to February 2011 in our hospital. The effect, visual acuity and complications were observed and analyzed. RESULTS: Followed up 6 to 24 months after surgery, all patients had no vitreous hemorrhage again, retinal blood vessels were occlusion around the arterial aneurysms, and then the arterial aneurysms shrinked and scared. The postoperative visual acuity improved from 0.05 to 0.4, all cases increase in varying degrees. The postoperative intraocular pressure of 2 cases (2 eyes) occurred a transient rise, then return to normal after given topical ocular hypotensive medication treatment. CONCLUSION: It is an effective and precise method of vitrectomy combined retinal photocoagulation for the treatment of vitreous hemorrhage with retinal arterial aneurysm.